CTOR
Citius Oncology, Inc.
NASDAQ: CTOR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.88
+2.31% today
Updated 2026-04-30
Market cap
$77.43M
P/E ratio
—
P/S ratio
19.63x
EPS (TTM)
$-0.31
Dividend yield
—
52W range
$0 – $6
Volume
0.3M
Citius Oncology, Inc. (CTOR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-47968.00 | $-601304.00 | $126353.00 | $-5.49M |
| Capital expenditures | $0.00 | $4.00 | $4.00 | $4.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $0.00 | $1.97M | $7.50M | $8.32M |
| Free cash flow | $-47968.00 | $-601308.00 | $126349.00 | $-5.49M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |